1. Home
  2. NKTR vs EGHT Comparison

NKTR vs EGHT Comparison

Compare NKTR & EGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • EGHT
  • Stock Information
  • Founded
  • NKTR 1990
  • EGHT 1987
  • Country
  • NKTR United States
  • EGHT United States
  • Employees
  • NKTR N/A
  • EGHT N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • EGHT EDP Services
  • Sector
  • NKTR Health Care
  • EGHT Technology
  • Exchange
  • NKTR Nasdaq
  • EGHT Nasdaq
  • Market Cap
  • NKTR 238.7M
  • EGHT 250.2M
  • IPO Year
  • NKTR 1994
  • EGHT 1997
  • Fundamental
  • Price
  • NKTR $1.36
  • EGHT $1.96
  • Analyst Decision
  • NKTR Buy
  • EGHT Buy
  • Analyst Count
  • NKTR 4
  • EGHT 6
  • Target Price
  • NKTR $2.50
  • EGHT $2.83
  • AVG Volume (30 Days)
  • NKTR 1.1M
  • EGHT 852.2K
  • Earning Date
  • NKTR 11-05-2024
  • EGHT 10-30-2024
  • Dividend Yield
  • NKTR N/A
  • EGHT N/A
  • EPS Growth
  • NKTR N/A
  • EGHT N/A
  • EPS
  • NKTR N/A
  • EGHT N/A
  • Revenue
  • NKTR $93,157,000.00
  • EGHT $723,565,000.00
  • Revenue This Year
  • NKTR N/A
  • EGHT $0.85
  • Revenue Next Year
  • NKTR N/A
  • EGHT $2.15
  • P/E Ratio
  • NKTR N/A
  • EGHT N/A
  • Revenue Growth
  • NKTR 6.17
  • EGHT N/A
  • 52 Week Low
  • NKTR $0.41
  • EGHT $1.51
  • 52 Week High
  • NKTR $1.93
  • EGHT $3.92
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 59.09
  • EGHT 50.53
  • Support Level
  • NKTR $1.24
  • EGHT $1.78
  • Resistance Level
  • NKTR $1.42
  • EGHT $2.20
  • Average True Range (ATR)
  • NKTR 0.09
  • EGHT 0.11
  • MACD
  • NKTR 0.01
  • EGHT -0.00
  • Stochastic Oscillator
  • NKTR 80.65
  • EGHT 42.86

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About EGHT 8x8 Inc

8x8 Inc provides contact-center-as-a-service and unified-communications-as-a-service software applications to approximately 2.5 million users. The company's unified platform enables omnichannel communication to assist employees in communicating across voice, video, text, chat, and contact centers. The Company also generates revenue from sales of hardware and professional services, which are complementary to the delivery of its integrated technology platform.. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: